SVF Endurance (Cayman) Ltd, 10% Owner at Vir Biotechnology, Inc. (VIR), sold 145,787 shares at $28.51 ($4.1M) on 2023-02-21, disclosed to the SEC on 2023-02-23.
Open-market sale of $4.1M VIR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.95 | 242 | $7K | 0.2% |
| 2 | $27.49 | 7,364 | $202K | 4.9% |
| 3 | $27.49 | 7,364 | $202K | 4.9% |
| 4 | $28.51 | 63,946 | $1.8M | 44.0% |
| 5 | $28.51 | 63,946 | $1.8M | 44.0% |
| 6 | $29.08 | 2,925 |
| $85K |
| 2.1% |
| Total | $28.42 avg | 145,787 | $4.1M | 100% |
| Filing → |
| VIR | SELL | 2025-10-30 | $319K | — | Filing → |
| VIR | SELL | 2025-10-22 | $2.7M | — | Filing → |
| VIR | SELL | 2025-10-17 | $359K | — | Filing → |